T-cell function is also impaired via GPR65 signalling, with experimental data demonstrating that GPR65 activity significantly inhibited antigen-specific, CD8+ T-cell cytotoxic activity against target cancer cells [65]. The gene discussed is GPR65; the disease is cancer.